This inventor holds 1 USPTO granted patent. Top assignee: Kowa Company Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Nao Yamasaki
Introduction
Nao Yamasaki is a prominent inventor based in Nerima-kui, Japan. With a focus on biomedical innovations, his work contributes significantly to the field of medicinal chemistry. He holds a total of one patent, showcasing his inventive prowess and dedication to improving health outcomes.
Latest Patents
Yamasaki's notable patent is for a condensed pyridine or condensed pyrimidine derivative, accompanied by a medicinal agent that includes this compound. This invention is aimed at providing a novel compound that promotes insulin secretion from pancreatic beta cells. This advancement holds promise for the prophylaxis and therapeutic treatment of hyperglycemia-related diseases, including diabetes mellitus. The compound is represented by a specific chemical formula, demonstrating its specialized application in medicine.
Career Highlights
Nao Yamasaki has made substantial strides in his career, particularly through his work at Kowa Company Limited, a well-respected entity in the pharmaceutical industry. His innovative contributions underscore his position as a key figure in the development of new therapeutic agents aimed at addressing critical health issues.
Collaborations
Throughout his career, Yamasaki has collaborated with esteemed colleagues such as Toshiharu Morimoto and Tomoaki Koshizawa. These partnerships highlight the importance of teamwork in the innovation process, facilitating the exchange of ideas and enhancing the development of new medicinal compounds.
Conclusion
With his singular patent and ongoing contributions to medicinal chemistry, Nao Yamasaki exemplifies the spirit of innovation. His work at Kowa Company Limited and collaborations with fellow inventors reflect a commitment to advancing medical science for the benefit of individuals suffering from diabetes and related conditions. As the demand for effective therapeutic solutions grows, the contributions of inventors like Yamasaki remain vital in shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile